Current approaches to diagnosis and treatment of patients with varicose veins C1

Authors

  • O.Yu. Atamanyuk Ivano-Frankivsk National Medical University

DOI:

https://doi.org/10.24144/2415-8127.2020.61.5-8

Keywords:

varicose veins, reticular veins, telangiectasia, sclerotherapy, percutaneous laser coagulation.

Abstract

The results of a prospective study of the diagnosis and treatment of 104 patients with varicose veins, clinical class C1 (telangiectasia and reticular veins) are presented in the paper.And the first time the proven effectiveness of the program VEIN SEEK pro for diagnosis and during treatment.Using photographic documentation and patient survey results on the Global Aesthetic Improvement Scale, the results of the treatment of patients with percutaneous laser coagulation and foam sclerotherapy were compared.According to the results of the study it is determined that the most common complication with the use of the proposed methods of treatment is residual pigmentation, which is observed in 3.8% of patients in whom transcutaneous laser coagulation is used and 6.4% – sclerotherapy.

References

Rabe E, Guex JJ, Puskas A, Scuderi A, Fernandez Quesada F, VCP Coordinators. Epidemiology of chronic venous disorders in geographically diverse populations: results from the Vein Consult program. Int Angiol. 2012;31(2):105–15.

O’Donnell TF Jr., Passman MA, and Marston WA. Management of venous leg ulcers: Clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum.J Vasc Surg 2014;60(2 Suppl.): 3S–59S.

www.veinseek.com

Antonella Savoia, Ciro Accardo, Fulvio Vannini. Basso Di Pasquale Alfonso Baldi. Outcomes in Thread Lift for Facial Rejuvenation:a Study Performed with Happy Lift™Revitalizing. Dermatol Ther (Heidelb) (2014) 4:103–114.

Published

2020-06-30

How to Cite

Атаманюк, О. . (2020). Current approaches to diagnosis and treatment of patients with varicose veins C1. Scientific Bulletin of the Uzhhorod University. Series «Medicine», (1 (61), 5-8. https://doi.org/10.24144/2415-8127.2020.61.5-8